未登录

W

Wenshuai Liu

复旦大学

H指数:19

被引数:1,123

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Soft Tissue Sarcoma Burden and Research Productivity: Global Patterns and Disparities, 1990-2021

软组织肉瘤负担与研究产出：全球模式和差异，1990-2021

Health Science Reports

IF2.1

2026-05-030

OAAI

A one-step strategy for rapid detection of sub-50 nm polystyrene nanoplastics using nanobody-based homogeneous immunoassay

Journal of Hazardous Materials

IF11.3

2026-01-280

PRE

The Role of Cell Metabolism in Skin Wound Healing

细胞代谢在皮肤伤口愈合中的作用

IF10.7

2025-11-190

PRE

Nanobodies in Immunoanalysis: From Molecular Engineering to Advanced Detection Strategies for Foodborne Natural Toxins

纳米抗体在免疫分析中的应用：从分子工程到食品源性天然毒素的高级检测策略

Chemistry – A European Journal

IF0

2025-07-240

PRE

3D printing of retainer for post-otoplasty morphology preservation

INTERNATIONAL JOURNAL OF BIOPRINTING

IF6

2024-07-290

OA

Glycopeptide-based multifunctional nanofibrous hydrogel that facilitates the healing of diabetic wounds infected with methicillin-resistant Staphylococcus aureus

ACTA BIOMATERIALIA

IF9.6

2024-06-014

PRE

Novel Polystyrene-Binding Nanobody for Enhancing Immunoassays: Insights into Affinity, Immobilization, and Application Potential

ANALYTICAL CHEMISTRY

IF6.7

2024-01-183

PRE

A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications

Biomaterials Science

IF5.7

2024-01-019

PRE

Streptomyces global regulators AfsR and AfsS interact to co-regulate antibiotic production and morphological development

MICROBIAL BIOTECHNOLOGY

IF5.2

2023-11-201

OA

Development of a highly sensitive immunoassay based on pentameric nanobodies for carcinoembryonic antigen detection

用于癌胚抗原检测的基于五聚体纳米抗体的高灵敏度免疫测定法的开发

ANALYTICA CHIMICA ACTA

IF6

2023-10-0110

PRE

Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway

CELLULAR ONCOLOGY

IF4.8

2023-09-133

PRE

Optimized silk fibroin nanoparticle functionalization with anti-CEA nanobody enhancing active targeting of colorectal cancer cells

BIOMEDICAL MATERIALS

IF3.7

2023-06-230

PRE

Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-272

OAAI

Lipidomics and Transcriptomics Differ Liposarcoma Differentiation Characteristics That Can Be Altered by Pentose Phosphate Pathway Intervention

IF3.7

2022-12-075

OAAI

Low expression of exosomal miR-150 predicts poor prognosis in colorectal cancer patients after surgical resections

IF2.9

2022-06-298

PRE

A novel silk fibroin protein-based fusion system for enhancing the expression of nanobodies in Escherichia coli

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

IF4.3

2022-03-0411

OAAI

Targeting and neutralizing human epididymis protein 4 by novel nanobodies to suppress ovarian cancer cells and attenuate cisplatin resistance

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2022-02-013

PRE

Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2021-11-1626

OAAI

RP11-616M22.7 recapitulates imatinib resistance in gastrointestinal stromal tumor

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2021-09-0111

OAAI

Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma

IF3.4

2020-10-2810

OAAI